FHIR
© HL7.org |
Server Home
|
XIG Home
|
XIG Stats
|
Server Source
|
FHIR
FHIR IG Statistics: FHIR Resources
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
BNW
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
nl
|
no
|
nz
|
pt
|
se
|
sl
|
stt
|
tw
|
uk
|
us
|
uv
|
vn
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US
18,400 resources
Type:
ActivityDefinition
ActorDefinition
Basic
CapabilityStatement
CodeSystem
ConceptMap
DataElement
ExampleScenario
GraphDefinition
ImplementationGuide
Measure
MessageDefinition
NamingSystem
OperationDefinition
PlanDefinition
Questionnaire
Requirements
SearchParameter
StructureDefinition
StructureMap
TerminologyCapabilities
TestScript
ValueSet
Text:
By Version
R2
: 0
R2B
: 0
R3
: 524
R4
: 17,438
R4B
: 0
R5
: 438
R6
: 0
By Authority
none: 1,998
hl7
: 16,400
national
: 2
Start
Prev
Rows 6600 - 6800
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
Auth
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.806
Osteoarthritis of right knee I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.807
Osteoarthritis of left knee I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.808
Osteoarthritis of right knee
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.809
Osteoarthritis of left knee
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.810
Hip Osteoarthritis SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.811
Hip Osteoarthritis I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.812
Hip Osteoarthritis
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.813
Hip joint surgery CPT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.814
Hip joint surgery SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.815
Hip joint surgery
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.816
Osteoarthritis of right hip I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.817
Osteoarthritis of left hip I10
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.818
Osteoarthritis of right hip SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.819
Osteoarthritis of left hip SCT
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.820
Osteoarthritis of right hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.821
Osteoarthritis of left hip
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.823
Aminoglycosides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.824
Carbapenems
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.826
Monobactams
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.827
Penicillins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.828
Antimycobacterials
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.829
Beta_lactamase
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.830
Cyclic lipopeptides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.831
Lincosamides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.832
Macrolides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.833
Amphenicol
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.834
Oxazolidinones
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.835
Fluoroquinolones
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.836
Sulfonamides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.837
Tetracyclines
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.838
Phosphonics
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.839
Pleuromutilin
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.840
Streptogramins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.841
Lipoglycopeptides
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.842
Nitroimidazoles
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.843
PIM_Hyd_Bus_Mir_Tra
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.844
Nitrofurans
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.845
Rifamycins
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.846
Glycylcycline
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.847
Pyrimidines
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.849
Antibiotics oral and parenteral
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.850
Medications_hyperkalemia
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.852
Hyperkalemia_ICD10
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.853
Hyperkalemia_SCT
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.854
Hyperkalemia Conditions
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.855
Medications_Chronic Hyperkalemia
active
2024-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.858
PIM_Alpha_Blockers_2
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.860
PIM_Ambulatory_Visits_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.862
PIM_Ambulatory_Visits_SNOMED
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.863
PIM_Thyroid_Stimulating_Hormone_(TSH)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.864
PIM_Triiodothyronine_(T3)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.865
PIM_Thyroxine_(T4)
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.866
PIM_Magnesium_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.867
PIM_BMP_CMP_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.868
PIM_URIC_ACID_LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.869
PIM_Migraine_Medications
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.870
PIM_Triptans
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.871
ICS_SABA Reliever
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.873
PIM_Asthma_COPD_Meds
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.874
PIM_Lipid_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.875
PIM_Hepatic_Function_Panel_CPTs
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.876
Alpha Glucosidase Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.877
Inflammatory bowel disease I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.878
Inflammatory bowel disease SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.879
Inflammatory bowel disease
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.880
Gastrointestinal obstruction SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.881
Gastrointestinal obstruction I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.882
Gastrointestinal obstruction
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.883
DPP4i Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.884
Multiple endocrine neoplasia type 2 (MEN II) SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.885
Multiple endocrine neoplasia type 2 (MEN II) I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.886
Multiple endocrine neoplasia type 2 (MEN II)
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.887
Gastroparesis SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.888
Gastroparesis I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.889
Gastroparesis
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.890
Meglitinide Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.891
Sulfonylurea Allergy Intolerance
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.892
Peripheral edema I10
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.893
Peripheral edema SCT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.894
Peripheral edema
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.895
TZD Allergy Intolerance
active
2025-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.896
PIM_Beta_Blockers
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.897
PIM_CCB_DHPs
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.898
PIM_Loop_Diuretics
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.899
PIM_Inhaled_Corticosteroids_(ICS)
active
2025-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.9
ACE inhibitors
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.90
ASCVD I10
active
2023-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.900
PIM_Leukotrienes
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.901
OIA_Asthma_COPD_Meds_Inhalers
active
2025-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.902
OIA_Asthma_COPD_Meds_Nebulizers
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.903
OIA_Asthma_COPD_Meds_Oral
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.904
OIA_GLP1_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.905
OIA_Insulin_Injectables
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.906
OIA_Oral_Hypoglycemics
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.907
OIA_DM1_DM2_Meds
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.908
Medium Dose ICS Formoterol
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.909
High Dose ICS Formoterol
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.910
CKD stage5OrESRD I10
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.911
CKD stage5OrESRD SCT
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.912
CKD stage5OrESRD
active
2024-05
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.914
Anxiety_I10
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.915
Anxiety_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.916
Anxiety
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.918
Stress_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.919
Stress_I10
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.920
Stress
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.921
PBH_Anxiety_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.922
PBH_Depression_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.923
PBH_Stress_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.924
PBH_Insomnia_SCT
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.925
PIM_CMP_CPTs
active
2024-06
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.926
Canagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.927
Empagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.928
Dapagliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.929
Ertugliflozin meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.930
Dulaglutide meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.931
Liraglutide meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.932
Semaglutide SC meds
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.933
T2DM meds benefitting ASCVD
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.934
T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.935
T2DM meds benefitting CKD stage 5
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.936
T2DM meds benefitting HF with eGFR >= 20 mL/min
active
2024-07
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.938
Crohn disease SCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.939
Crohn disease I10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.940
Crohn disease
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.941
Celiac disease SCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.942
Celiac disease I10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.943
Celiac disease
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.944
OIA_Bisoprolol
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.945
OIA_PVD_ICD10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.946
Vibration Controlled Transient Elastography (VCTE)
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.947
OIA_Antihypertensive_Medications
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.950
OIA_CAD_ICD10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.951
OIA_DM_ICD10
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.952
OIA_Creatinine_Levels_LOINC
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.953
OIA_DM_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.954
OIA_CAD_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.955
OIA_PVD_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.956
OIA_DM_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.957
OIA_CAD_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.958
OIA_PVD_ICD10_SNOMEDCT
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.959
ACEi for HFrEF
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.960
ARB for HFrEF
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.961
OIA_AntiHTN_Meds_Inclusion_List
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.962
OIA_Thiazide_Diuretics
active
2024-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.963
OIA_RFs_ACS_ICD10
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.964
OIA_RFs_ACS_SNOMED
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.965
OIA_RFs_ACS__ICD10_SNOMED
active
2024-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.966
OIA_Aortic_Calcifications_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.967
OIA_Aortic_Calcifications_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.968
OIA_Aortic_Calcifications_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.969
OIA_Microalbumin
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.97
Sulfonylurea AllergyIntolerance SCT
active
2023-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.970
OIA_LDL_Cholesterol
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.971
Pioglitazone
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.972
MASLD I10
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.973
MASLD SCT
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.975
OIA_Sulfonylureas
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.978
OIA_RFs_ASCVD_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.979
OIA_RFs_ASCVD_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.98
BMI LOINC
active
2024-03
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.980
OIA_RFs_ASCVD_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.981
OIA_TIA_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.982
OIA_TIA_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.983
OIA_TIA_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.984
OIA_Angina_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.985
OIA_Angina_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.987
OIA_Angina_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.988
OIA_Ischemic_Hemorrhagic_Stroke_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.989
OIA_Ischemic_Hemorrhagic_Stroke_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.990
OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.991
OIA_Myocardial_Infarction_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.992
OIA_Myocardial_Infarction_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.993
OIA_Myocardial_Infarction_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.995
OIA_PAD_ICD10
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.996
OIA_PAD_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.997
OIA_PAD_ICD10_SNOMED
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1078.998
OIA_Coronary_Arterial_Revascularization
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1080.5
Contact or Office Visit
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1080.6
Contact or Office Visit
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1080.7
Contact or Office Visit
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.10
Nutrition Diagnosis SNOMED CT
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.101
Hospice Status
active
2024-10
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.14
Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT
active
2020-08
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.17
Pediatric Enteral Formulas SNOMED CT
active
2021-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.18
Modified Amino Acid Formulas SNOMED CT
active
2024-04
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.19
Nutrition Counseling Approach and Strategies SNOMED CT
active
2020-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.20
Enteral Nutrition Management SNOMED CT
active
2020-09
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.21
Nutrition Assessment
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.25
Nutritional Status Severely Malnourished
active
2016-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.30
Malnutrition Risk Screening
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.31
Malnutrition At Risk
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.32
Malnutrition Risk Screening
active
2016-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.34
Malnutrition Screening Finding of Not At Risk Result
active
2024-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.35
Malnutrition Screening Not at Risk
active
2015-11
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.38
Malnutrition Screening Finding of At Risk Result
active
2025-01
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.39
Malnutrition Risk Screening
active
2016-12
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.40
Malnutrition Risk Screening
active
2022-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.41
Nutritional Status Severely Malnourished
active
2025-02
hl7
us.nlm.vsac
R4
ValueSet/2.16.840.1.113762.1.4.1095.42
Nutrition Assessment Status Finding of Severely Malnourished
active
2024-12
hl7